[
  {
    "ts": null,
    "headline": "West Pharmaceutical Services Inc. stock rises Monday, still underperforms market",
    "summary": "West Pharmaceutical Services Inc. stock rises Monday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=41e1de8ab977c2249d8542abadc11ff26a855cf533d4d3b3e1d445a3d1b1a05c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747069920,
      "headline": "West Pharmaceutical Services Inc. stock rises Monday, still underperforms market",
      "id": 134421407,
      "image": "",
      "related": "WST",
      "source": "MarketWatch",
      "summary": "West Pharmaceutical Services Inc. stock rises Monday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=41e1de8ab977c2249d8542abadc11ff26a855cf533d4d3b3e1d445a3d1b1a05c"
    }
  },
  {
    "ts": null,
    "headline": "Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST",
    "summary": "NEW YORK, May 12, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc.  .  Such investors are advised to contact...",
    "url": "https://finnhub.io/api/news?id=950ccb793549416d273116929f28f1ebe42c66212711a25deef8e3d93d32b3e3",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747058765,
      "headline": "Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST",
      "id": 134390469,
      "image": "",
      "related": "WST",
      "source": "Finnhub",
      "summary": "NEW YORK, May 12, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc.  .  Such investors are advised to contact...",
      "url": "https://finnhub.io/api/news?id=950ccb793549416d273116929f28f1ebe42c66212711a25deef8e3d93d32b3e3"
    }
  },
  {
    "ts": null,
    "headline": "Law Offices of Howard G. Smith Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action",
    "summary": "Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased West Pharmaceutical Services, Inc. common stock between February 16, 2023 and...",
    "url": "https://finnhub.io/api/news?id=764a677c979c917d35a3b2a64a9df9097acfd9d4eb85c007470544f6d7191c89",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747051263,
      "headline": "Law Offices of Howard G. Smith Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action",
      "id": 134383322,
      "image": "",
      "related": "WST",
      "source": "Finnhub",
      "summary": "Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased West Pharmaceutical Services, Inc. common stock between February 16, 2023 and...",
      "url": "https://finnhub.io/api/news?id=764a677c979c917d35a3b2a64a9df9097acfd9d4eb85c007470544f6d7191c89"
    }
  },
  {
    "ts": null,
    "headline": "WST Q1 Earnings Call: Revenue Guidance Raised, Margins Impacted by Product Mix and Tariffs",
    "summary": "Healthcare products company West Pharmaceutical Services (NYSE:WST) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $698 million. The company’s full-year revenue guidance of $2.96 billion at the midpoint came in 1.8% above analysts’ estimates. Its non-GAAP profit of $1.45 per share was 15.3% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=2e8b8de20e041334612232e3741bc651da12456dbf2d6ea74cfe7427adef65c6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747041341,
      "headline": "WST Q1 Earnings Call: Revenue Guidance Raised, Margins Impacted by Product Mix and Tariffs",
      "id": 134379849,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "Healthcare products company West Pharmaceutical Services (NYSE:WST) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $698 million. The company’s full-year revenue guidance of $2.96 billion at the midpoint came in 1.8% above analysts’ estimates. Its non-GAAP profit of $1.45 per share was 15.3% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=2e8b8de20e041334612232e3741bc651da12456dbf2d6ea74cfe7427adef65c6"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - WST",
    "summary": "NEW YORK, May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. . ...",
    "url": "https://finnhub.io/api/news?id=243db86b74020e41c5930011ee1afff8c69d98cbf87da44e8058542769097e64",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747028776,
      "headline": "West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - WST",
      "id": 134376653,
      "image": "",
      "related": "WST",
      "source": "Finnhub",
      "summary": "NEW YORK, May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. . ...",
      "url": "https://finnhub.io/api/news?id=243db86b74020e41c5930011ee1afff8c69d98cbf87da44e8058542769097e64"
    }
  },
  {
    "ts": null,
    "headline": "High-Quality Dividend Growth Stocks Near 52-Week Lows: Alphabet Is Astounding",
    "summary": "A list of high-quality dividend-growth stocks trading near 52-week lows is evaluated. Read what makes GOOG stock is a compelling investment.",
    "url": "https://finnhub.io/api/news?id=271defdcaa1d7c4f740989245dac0be0fae96377b5585e7fe2fa2cba60148ce3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747013223,
      "headline": "High-Quality Dividend Growth Stocks Near 52-Week Lows: Alphabet Is Astounding",
      "id": 134374993,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1400200369/image_1400200369.jpg?io=getty-c-w1536",
      "related": "WST",
      "source": "SeekingAlpha",
      "summary": "A list of high-quality dividend-growth stocks trading near 52-week lows is evaluated. Read what makes GOOG stock is a compelling investment.",
      "url": "https://finnhub.io/api/news?id=271defdcaa1d7c4f740989245dac0be0fae96377b5585e7fe2fa2cba60148ce3"
    }
  }
]